(Q39766604)

14 September 2017

Increased iron and oxidative stress are separately related to cognitive decline in elderly (English)

1 reference

14 September 2017

Elcin E Umur

1

1 reference

14 September 2017

Cagatay Oktenli

2

1 reference

14 September 2017

Serkan Celik

3

1 reference

14 September 2017

Fatih Tangi

4

1 reference

14 September 2017

Ozkan Sayan

5

1 reference

14 September 2017

Yavuz S Sanisoglu

6

1 reference

14 September 2017

Osman Ipcioglu

7

1 reference

14 September 2017

Hakan M Terekeci

8

1 reference

14 September 2017

Cihan Top

9

1 reference

14 September 2017

Selim Nalbant

10

1 reference

14 September 2017

Yasar Kucukardali

11

1 reference

14 September 2017

language of work or name

1 reference

30 March 2011

1 reference

Geriatrics and Gerontology International

14 September 2017

1 reference

14 September 2017

11

1 reference

14 September 2017

4

1 reference

14 September 2017

504-509

1 reference

Aging: an important factor for the pathogenesis of neurodegenerative diseases

14 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Changing perspectives regarding late-life dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Neural mechanisms of ageing and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Lipid metabolism in cognitive decline and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Molecular mechanisms of normal iron homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Brain iron deficiency and excess; cognitive impairment and neurodegeneration with involvement of striatum and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Relationship between anaemia and cognitive functions in elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Reactive oxygen species and the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Increased oxidative stress and hypozincemia in male obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Detrimental effects of N-acetylcysteine plus desferoxamine combination in an experimental nephrotic syndrome model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Effects of N-acetylcysteine, deferoxamine and selenium on doxorubicin-induced hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Survival responses to oxidative stress and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Reactive oxygen species: influence on cerebral vascular tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Neuroprotective role of neurokinin B (NKB) on beta-amyloid (25-35) induced toxicity in aging rat brain synaptosomes: involvement in oxidative stress and excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Brain iron deposition and the free radical-mitochondrial theory of ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Hippocampal neurodegeneration in aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Cognitive decline is associated with systemic oxidative stress: the EVA study. Etude du Vieillissement Artériel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Reactive oxygen species and synaptic plasticity in the aging hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Oxidative stress and aberrant signaling in aging and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

The Mini-Mental State Examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Inhibition of iron-catalyzed oxidations by attainable uric acid and ascorbic acid levels: therapeutic implications for Alzheimer's disease and late cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Redox metals in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Blood transferrin and ferritin in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Nanoparticle and iron chelators as a potential novel Alzheimer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Role of iron in neurotoxicity: a cause for concern in the elderly?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Iron and oxygen radicals in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Brain ferritin iron may influence age- and gender-related risks of neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Iron, brain ageing and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Could a dysfunction of ferritin be a determinant factor in the aetiology of some neurodegenerative diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Biomarkers in Alzheimer's disease: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Oxidative damage is the earliest event in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

The lipid peroxidation products as possible markers of Alzheimer's disease in blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Oxidative damage in mild cognitive impairment and early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Oxidative stress hypothesis in Alzheimer's disease: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

Iron status and oxidative stress biomarkers in adults: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2011.00694.X

10.1111/J.1447-0594.2011.00694.X

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference